scispace - formally typeset
S

Siarhei A. Dabravolski

Researcher at Central European Institute of Technology

Publications -  44
Citations -  556

Siarhei A. Dabravolski is an academic researcher from Central European Institute of Technology. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 6, co-authored 23 publications receiving 218 citations. Previous affiliations of Siarhei A. Dabravolski include Palacký University, Olomouc.

Papers
More filters
Journal ArticleDOI

Dirigent proteins in plants: modulating cell wall metabolism during abiotic and biotic stress exposure.

TL;DR: The ample evidence for stress-induced dirigent gene expression is summarized, suggesting the role of DIRs in adaptive responses, and a preliminary bioinformatics-based characterization of the AtDIR family is presented.
Journal ArticleDOI

Illuminating light, cytokinin, and ethylene signalling crosstalk in plant development

TL;DR: Evidence indicating that multiple hormonal and light signals are integrated in the multistep phosphorelay (MSP) pathway, a backbone signalling pathway in plants, clearly demonstrates the crucial integration of plant responses to phytohormones and adaptive responses to environmental cues.
Journal ArticleDOI

Phylogenetic Diversity and Physiological Roles of Plant Monovalent Cation/H+ Antiporters.

TL;DR: The data suggest that the multiplication and complexation of CPA isoforms during evolution is related to land colonisation by higher plants and associated with an increase of different tissue types and development of reproductive organs.
Journal ArticleDOI

Post‐Translational Modifications of Histones in Human Sperm

TL;DR: Data indicate that particular post‐translational modifications of histones are uniquely distributed in human sperm, and this distribution varies among individuals and among the sperm of a single individual.
Journal ArticleDOI

The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets

TL;DR: Several modern anti-atherosclerosis VEGFs-targeted experimental procedures, drugs and natural compounds, which could significantly improve the efficiency of atherosclerosis and related CVDs’ treatment are discussed.